| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5654804 | Clinical Immunology | 2017 | 35 Pages |
Abstract
In SVR patients, myeloid DC frequency transiently decreased, and returned to baseline level when telaprevir was stopped. Moreover, an up-regulation of CD80 and CD86 on mDC was observed in SVR patients as well as an improvement of IFN-α production by plasmacytoid DC, able to inhibit in vitro HCV replication.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alessandra Sacchi, Nicola Tumino, Federica Turchi, Giulia Refolo, GianMaria Fimia, Fabiola Ciccosanti, Marzia Montalbano, Raffaella Lionetti, Chiara Taibi, Gianpiero D'Offizi, Rita Casetti, Veronica Bordoni, Eleonora Cimini, Federico Martini,